[Federal Register Volume 61, Number 69 (Tuesday, April 9, 1996)]
[Rules and Regulations]
[Page 15703]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-8762]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
21 CFR Part 510
New Animal Drugs; Change of Sponsor Name
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect a change of sponsor name from A. L. Pharma,
Inc., to ALPHARMA INC.
EFFECTIVE DATE: April 9, 1996.
FOR FURTHER INFORMATION CONTACT: Thomas J. McKay, Center for Veterinary
Medicine (HFV-102), Food and Drug Administration, 7500 Standish Pl.,
Rockville, MD 20855, 301-827-0213.
SUPPLEMENTARY INFORMATION: A. L. Pharma, Inc., One Executive Dr., Fort
Lee, NJ 07024, has informed FDA of a change of sponsor name to ALPHARMA
INC. Accordingly, FDA is amending the regulations in 21 CFR
510.600(c)(1) and (c)(2) to reflect the change of sponsor name.
List of Subjects in 21 CFR Part 510
Administrative practice and procedure, Animal drugs, Labeling,
Reporting and recordkeeping requirements.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs and
redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is
amended as follows:
PART 510--NEW ANIMAL DRUGS
1. The authority citation for 21 CFR part 510 continues to read as
follows:
-Authority: Secs. 201, 301, 501, 502, 503, 512, 701, 721 of the
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321, 331, 351, 352,
353, 360b, 371, 379e).
Sec. 510.600 [Amended]
2. Section 510.600 Names, addresses, and drug labeler codes of
sponsors of approved applications is amended in the table in paragraph
(c)(1) by removing the entry for ``A. L. Pharma, Inc.'' and by
alphabetically adding a new entry for ``ALPHARMA INC.'' and in the
table in paragraph (c)(2) in the entry ``046573'' by removing the
sponsor name ``A. L. Pharma, Inc.'' and adding in its place ``ALPHARMA
INC.''
Dated: March 28, 1996.
Robert C. Livingston,
Director, Office of New Animal Drug Evaluation, Center for Veterinary
Medicine.
[FR Doc. 96-8762 Filed 4-8-96; 8:45 am]
BILLING CODE 4160-01-F
